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This work contributes to the understanding of cell wall modifications during sporulation and 
germination in Streptomyces by assessing the biological function and biochemical properties of 
SCO4439, a D-alanyl-D-alanine carboxypeptidase (DD-CPase) constitutively expressed during 
development. SCO4439 harbors a DD-CPase domain and a putative transcriptional regulator domain, 
separated by a putative transmembrane region. The recombinant protein shows that DD-CPase activity 
is inhibited by penicillin G. The spores of the SCO4439::Tn5062 mutant are affected in their resistance 
to heat and acid and showed a dramatic increase in swelling during germination. The mycelium 
of the SCO4439::Tn5062 mutant is more sensitive to glycopeptide antibiotics (vancomycin and 
teicoplanin). The DD-CPase domain and the hydrophobic transmembrane region are highly conserved 
in Streptomyces, and both are essential for complementing the wild type phenotypes in the mutant. A 
model for the biological mechanism behind the observed phenotypes is proposed, in which SCO4439 
DD-CPase releases D-Ala from peptidoglycan (PG) precursors, thereby reducing the substrate pool for 
PG crosslinking (transpeptidation). PG crosslinking regulates spore physical resistance and germination, 
and modulates mycelium resistance to glycopeptides. This study is the first demonstration of the role of 
a DD-CPase in the maturation of the spore cell wall.
Streptomycetes are mycelial microorganisms characterized by their complex developmental cycles, includ-
ing programmed cell death (PCD) and hyphae differentiation, which leads to aerial mycelium formation and 
sporulation1,2. Streptomycetes are important industrial bacteria producing approximately two-thirds of clinical 
antibiotics, as well as a large number of eukaryotic cell differentiation inducers and inhibitors3. Most of these 
bioactive compounds are specialized metabolites4, the production of which is regulated, at least in part, by hyphal 
differentiation5. Streptomyces development, is activated by extracellular signals, including nutritional stimuli or 
cell density (quorum sensing), and is regulated by complex signaling pathways that are only partially known5–7. 
The best-characterized stages of Streptomyces development are those related to aerial mycelium and sporulation. 
Several key regulatory networks controlling these stages have been characterised (bald, sky or white pathways, 
reviewed in Flärdh and Buttner1). Despite this, the regulation of aerial mycelium and sporulation remains incom-
pletely understood, and new genes and proteins regulating these important processes, are still being discovered8. 
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Stages preceding aerial mycelium, including spore germination and differentiation in liquid non-sporulating 
cultures, are even less characterized and comprehended2,9.
D-alanyl-D-alanine carboxypeptidases (DD-CPases) are members of the penicillin binding proteins (PBPs), 
a family of proteins inhibited by ß-lactam antibiotics involved in peptidoglycan (PG) synthesis and remodelling. 
The PBPs constitute a family of acyltransferases with a common evolutionary origin and a common substrate 
(the D-Ala-D-Ala dipeptides present in the pentapeptide stems of PG precursors), that are collectively known 
as DD-peptidases. DD-peptidases include transglycosylases, which catalyze the polymerization of glycan chains 
composed of N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM); DD-CPases, which remove the ter-
minal D-alanine from muramyl pentapeptide; transpeptidases, which catalyze the cross-link formation between 
one D-Ala of one PG strand and one amino acid of the other strand; and endopeptidases, which cleave the 
cross-linked peptide side-chains10. The DD-peptidases are classified on the basis of their molecular mass, amino 
acid sequence and enzyme activity at high molecular mass (HMM) and low molecular mass (LMM)11–13. HMM 
DD-peptidases are usually bifunctional transglycosylases/transpeptidases (also classified as class A), or mono-
functional transpeptidases (class B) anchored to membranes. LMM DD-peptidases are monofunctional carboxy-
peptidases or endopeptidases, and the majority are also anchored to membranes (class C). LMM DD-peptidases 
are usually not essential, and they are not found in most studies and reviews on PBPs13.
Most bacteria have multiple PBPs with varying degrees of redundant activity. A phylogenetic analysis revealed 
that Actinobacteria have an average of five HMM DD-peptidases per genome; this number doubled only in 
streptomycetes (13 DD-peptidases in the case of S. coelicolor)13. Many DD-peptidases belong to the SEDS (shape, 
elongation, division, and sporulation) clusters of genes involved in PG synthesis and remodeling and are essen-
tial for growth, cell division, and cellular viability. DD-peptidases that are not included in the SEDS clusters 
are considered dispensable for growth and viability10, and their biological function remains poorly investigated. 
Streptomyces coelicolor harbors four SEDS clusters14, that include four transpeptidases (SCO2090, SCO2608, 
SCO3847 and SCO5301).
This work contributes characterizing the biological function of the largely ignored redundant and 
non-essential LMM DD-peptidases by studying the activity and role of SCO4439, a gene encoding a putative 
DD-CPase. SCO4439 is a very unusual DD-CPase that is highly conserved in streptomycetes and is therein fused 
with a putative transcriptional regulator domain (see below). SCO4439 was found to be slightly over-expressed 
during the aerial mycelium and sporulation stages15, however, its biological role remained unclear.
Results
Mutation of SCO4439 affects spore swelling during germination, increases spore resistance to 
acid/heating and reduces the glycopeptide resistance. Cosmid D6.2.B06_046 harboring a copy of 
SCO4439 interrupted by Tn5062 was used to obtain the S. coelicolor SCO4439::Tn5062 mutant using the method-
ology developed by Fernández-Martínez et al.16. The early stages of SCO4439::Tn5062 mutant spore germination 
were similar to those in the S. coelicolor wild strain (Fig. 1a–h); however SCO4439::Tn5062 mutant showed a 
clear and distinctive phenotype at later stages, consisting of a dramatic increase in spore swelling (Fig. 1k,l) with 
respect to the wild-type strain (Fig. 1i,j).
The kinetics of spore germination in the S. coelicolor wild type and in the SCO4439::Tn5062 mutant were 
studied by using time-lapse confocal microscopy (Fig. 1m,n and Supplementary Movies 1 and 2). The spores of 
the S. coelicolor parental strain swelled until they reached a diameter of 2.3 ± 0.4 μ m (5-hour culture), before the 
emergence of the germ tube, which coincided with a deswelling and a consequent reduction of the spore diameter 
(from 2.3 ± 0.4 μ m at 5-hours to 1.2 ± 0.4 μ m at 8-hours) (Fig. 1m,r). At early time points, the swelling of the 
spores of the SCO4439::Tn5062 mutant was slower than the swelling of the spores of the wild strain (compare 
5 hour-time in Fig. 1m,n), but they continued to swell after the emergence of the germ tube, reaching a diameter 
that was the double that of the wild type spores (3.2 μ m ± 0.4 μ m) before deswelling and reducing the spore diam-
eter (Fig. 1n,r). Another difference between the wild type and the SCO4439::Tn5062 mutant was that, after germi-
nation and deswelling, the cell membrane permeability inside the spores remained intact in the wild type strain 
(SYTO9 staining, Fig. 1o), but not in the SCO4439::Tn5062 mutant (PI staining, Fig. 1p). The increase in spore 
swelling affected 100% of the SCO4439::Tn5062 mutant spores at 15–18 hours (average diameter of 3.1 ± 0.4 μ m, 
Fig. 1r).
Contrary to expectations16, DNA sequencing demonstrated that the insertion of Tn5062 into cosmid 
D6.2.B06_046 generated a deletion. Tn5062 was inserted at position 640 of SCO4439 and 669 of SCO4440, gen-
erating a loss of 1,641 bp, which affected the 5′ -terminus of SCO4439 and most of the SCO4440 open reading 
frame (ORF) (schematized in Fig. 2a). The deletion of the 5′ -terminus of SCO4439 may affect the expression of 
SCO4437 and SCO4438 (both located downstream of SCO4439), whereas the deletion of SCO4440 may affect 
the expression of SCO4441 and SCO4442 (Fig. 2a). To identify the gene responsible for the observed phenotype, 
plasmid pMS8217 was used to introduce different fragments of the SCO4437-SCO4442 chromosomal region, 
into the SCO4439::Tn5062 mutant strain (schematized in Fig. 2b). The only DNA fragments complementing the 
wild-type phenotype were those including SCO4439, as was the case for plasmid pBRB3 (compare Fig. 2c with 
Fig. 1k,l) (Supplementary Movie 3). Similar results were obtained in the SCO4439::Tn5062 mutant harboring 
plasmid pBRB2 but not in the mutant strain harboring plasmid pBRB1 (data not shown).
As introduced above, the SCO4439 gene was previously reported to be slightly over-expressed during aerial 
mycelium and sporulation in microarray-based transcriptomic analyses; however differences in expression were 
too low to be considered significant15 (Fig. 2e). In this work, RT-PCR analyses confirmed the expression pattern 
of SCO4439 (Fig. 2e).
The spore resistance profiles of the SCO4439::Tn5062 mutant and the wild type strains were compared 
(Fig. 3). Lysozyme treatment increases germination, and sonication kills 99% of the spores in the S. coeli-
color wild strain. The SCO4439 mutation did not affect resistance to the lysozyme, to sonication or to freezing 
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(Fig. 3a–c) but increased fivefold the spore resistance to acid and heating compared with the parental strain and 
the SCO4439::Tn5062 complemented mutant (Fig. 3d,e).
Mycelium resistance to glycopeptides (vancomycin and teicoplanin) was reduced in the SCO4439::Tn5062 
mutant (minimum inhibitory concentrations of 110 and 0.7 μ g/ml, respectively), in respect to the S. coelicolor 
wild type strain (minimum inhibitory concentrations 140 and 0.9 μ g/ml) (Fig. 3f).
SCO4439 harbors two protein domains separated by a putative hydrophobic transmembrane 
region. SCO4439 encodes a multi-domain protein harboring a DD-CPase (conserved domain database 
Figure 1. Analysis of the germination stages in S. coelicolor wild type and in S. coelicolor SCO4439::Tn5062 
mutant. (a–l) Confocal laser-scanning fluorescence microscopy analysis (SYTO9/PI staining) of the S. 
coelicolor wild type (left panel) and SCO4439::Tn5062 mutant (right panel). The same samples were observed 
using the fluorescence (left pictures) or interference contrast modes (right pictures). Bars indicate 8 μ m (m,n) 
Time-lapse confocal microscopy (interference contrast mode) of the germination of spores from the wild type 
and of the SCO4439::Tn5062 mutant, respectively. Spore diameters are indicated. (o,p) Confocal laser-scanning 
fluorescence microscopy analysis (SYTO9/PI staining) and interference contrast images of spore swelling and 
spore deswelling stages in the wild type and SCO4439::Tn5062 mutant, respectively. (q) Time-lapse confocal 
microscopy of the germination of spores from the SCO4439::Tn5062 mutant harboring the SCO4439* mutated 
gene (SCO4439::Tn5062[pBRB3*] strain). Time-lapse experiments were limited to 12 hours (see Methods for 
details). Arrows indicate spores. Asterisks indicate swelled spores. (r) Quantification of the spore diameters 
(average ± SD) of the wild type, SCO4439::Tn5062 mutant, and SCO4439::Tn5062[pBRB3*] strain at 5, 8 and 
15 hours.
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accession COG1686), and a putative transcriptional regulator (conserved domain database accession PHA03307) 
(Fig. 4a). According to the Phobius software prediction (http://phobius.sbc.su.se/), these two domains are sepa-
rated by a putative transmembrane region (Fig. 4a). The DD-CPase domain and the putative hydrophobic trans-
membrane domain are highly conserved in the Streptomyces genus (70% average similarity in Streptomyces) and 
actinomycetes in general (data not shown). The conservation of the transcriptional regulatory domain is sub-
stantially lower (44% average similarity in Streptomyces), and this domain is not present in other actinomycetes.
Different fragments of the SCO4439 gene were introduced into the SCO4439::Tn5062 mutant strain, using 
pMS82 as the integrative carrier vector (see Materials and Methods for details and scheme in Fig. 4a). The only 
fragments that complemented the wild-type phenotype were those containing both, the transmembrane and 
DD-CPase domains (data not shown).
Amino acid sequence alignment of the S. coelicolor DD-CPase domain (Fig. 4b) showed an overall high 
identity with the orthologous proteins from the six model Streptomyces strains analyzed, including the triad of 
“SxxK”, “SxN” and “KTG” motifs that characterize the “SxxK” superfamily of penicillin-binding DD-peptidases11. 
Interestingly, a replacement of Leu684 by Pro (randomly generated by PCR, see Methods) partially blocked the 
phenotype complementation in spore swelling in the SCO4439::Tn5062 mutant (Fig. 1q). As discussed below, 
the maximum spore-swelling of the SCO4439::Tn5062 mutant strain harboring the mutated SCO4439* gene 
(SCO4439::Tn5062 [pBRB3*] strain) was 3.9 μ m (Fig. 1q), which is an intermediate value between the wild type 
(2.3 μ m) and the SCO4439:Tn5062 mutant (4.5 μ m) spore diameters (Fig. 1m,n,q,r; Supplementary Movie 4).
SCO4439 carboxypeptidase activity. The SCO4439 protein and its mutated version SCO4439* (muta-
tion replacing Leu684 with Pro684, see above) were over-expressed in E. coli, and purified using His-tag affinity 
chromatography (Fig. 5a). The identity of the overproduced proteins was confirmed via peptide mass fingerprint-
ing (data not shown).
The enzymatic activities of the purified SCO4439 and SCO4439* were assayed on D-Ala-D-Ala dipeptide and 
on the tripeptide Nα,Nε-diacetyl-l-Lys-D-Ala-D-Ala, which mimics the terminal portions of the PG pentapeptide 
precursors17,18. SCO4439 and SCO4439* cleaved the D-Ala from the tripeptide and, to a lesser extent, from the 
dipeptide D-Ala-D-Ala. Thus, they showed a significantly higher DD-CPase activity than DD-dipeptidase activity 
(Fig. 5b). The enzyme activity of the mutated SCO4439* was half that of the non-mutated protein (Fig. 5b and 
Figure 2. Complementation of the wild-type phenotype in the SCO4439::Tn5062 mutant, and SCO4439 
gene expression during development. (a) Scheme of the SCO4437-SCO4442 region in the wild type and the 
SCO4439::Tn5062 mutant. The dashed line indicates the chromosome deletion generated by the transposon 
insertion. (b) Scheme illustrating the fragments introduced into the mutant strain using plasmids pBRB1, 
pBRB2 and pBRB3. Fragments that complemented the phenotype in the mutant strain are highlighted in red.  
(c) Confocal laser fluorescence microscopy analysis of the S. coelicolor wild-type strain harboring pMS82 
(control), and the S. coelicolor SCO4439::Tn5062 mutant strain harbouring pBRB3 (complementation of the 
phenotype is also observed with pBRB2 but not with pBRB1). Samples were observed using the fluorescence 
(left pictures) or interference contrast modes (right pictures). Arrows indicate spores. (d) Quantification 
of spore diameters (average ± SD) in the wild type harboring pMS82 and in the SCO4439::Tn5062 mutant 
harboring pBRB3. (e) SCO4439 gene abundance at 12, 24, 48 hours (aerial mycelium) and 72 hours (spores). 
Data represent the fold change with respect to the 12 hour time point (qRT-PCR and microarray values). 
Microarray data are from Yagüe et al.2.
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discussed below). As expected, due to the presence of the canonical Ser-x-x-Lys motif present in SCO4439, the 
enzyme activity was inhibited by penicillin G (IC50 of 1 mM, Fig. 5c). As a control, no DD-CPase/DD-dipeptidase 
activity was detectable in the E.coli host transformed with the empty expression vectors (data not shown).
The DD-CPase/DD-dipeptidase activity of SCO4439 was then assayed in extracts from wild type S. coeli-
color, the SCO4439::Tn5062 mutant, and the complemented mutant. The DD-CPase/DD-dipeptidase activity was 
always detectable in insoluble fractions (membranes and cell wall debris) from the S. coelicolor wild-type strain 
and the complemented mutant, but not in those from the S. coelicolor SCO4439::Tn5062 mutant (Fig. 5d,e). There 
was no detectable activity in the cytosolic fractions from any of the two strains (data not shown). Interestingly, 
the specific DD-CPase enzymatic activity was slightly higher at the early time points after germination (16 hours) 
than in the substrate (30 hours) or aerial (72 hours) mycelium stages (Fig. 5d). As expected, incubation of the 
insoluble fractions with penicillin G abolished the enzyme’s activity (data not shown).
The spore PG crosslinking index (ratio between cross-linked glycine and total glycine) was estimated by 
adapting the 1-fluoro-2,4-dinitrobenzene (FDNB) method originally described for Bacillus19 to Streptomyces 
(see Methods for details) (Fig. 5f). As discussed below, the spores of the S. coelicolor SCO4439::Tn5062 mutant 
had 20% more crosslinking than the spores of the wild type strain. Interestingly, the PG crosslinking of the 
SCO4439::Tn5062 harboring the mutated SCO4439* gene (SCO4439::Tn5062 [pBRB3*]) were at an intermediate 
level in PG crosslinking between the SCO4439::Tn5062 mutant and the wild type strain (10% more crosslinking 
than the spores of the wild type strain; Fig. 5f).
PG synthesis during spore swelling and germination. Peptidoglycan synthesis during spore germi-
nation and swelling was analyzed using fluorescent BODIPY-vancomycin20 (Fig. 6). BODIPY-vancomycin pref-
erentially stains nascent PG, the staining of which protrudes above the areas in which there is no PG synthesis20. 
No PG synthesis occurred during the spore germination and swelling early stages in the wild and complemented 
strains, at least in the amount detectable by BODIPY-vancomycin staining (Fig. 6). Only at the latest stages of 
spore swelling, some areas of PG synthesis become detectable in the swelled spores of the mutant strain (Fig. 6j).
Discussion
The aim of this work was the characterization of SCO4439, a DD-CPase constitutively expressed during develop-
ment (Fig. 2e), and whose enzymatic activity is present during all developmental stages analyzed (Fig. 5d). The 
best characterized DD-peptidases are those belonging to the SEDS genes involved in PG synthesis/remodeling 
which are essential for growth, cell division, and viability. However, with very few exceptions, the biological role 
Figure 3. Spore resistance to physicochemical stresses and mycelium resistance to glycopeptides 
(vancomycin and teicoplanin). (a) Spore resistance to freezing. (b) lysozyme. (c) sonication. (d) acid.  
(e) heating. (f) Minimum inhibitory concentrations of vancomycin and teicoplanin towards S. coelicolor. The 
(1) effect on germination of the treated spores with respect to the untreated spores, and the (2) MIC values 
were estimated for the S. coelicolor wild-type strain (wt), SCO4439::Tn5062 mutant (SCO4439 mutant), 
SCO4439::Tn5062 complemented with pBRB3 (complemented mutant) and the control wild type strain 
harboring pMS82 (wt pMS82). Note that lysozyme treatment increased germination in all strains. Asterisks 
indicate a significant increase in resistance to acid and heating in the mutant strain. Percentages of germination 
are the average ± SD of three replicates; MIC values were estimated using three biological replicates; SD = 0.
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of other redundant DD-peptidases, not included in the SEDS clusters, such as SCO4439, remains unknown19,21. 
SCO4439 is not essential for growth; however its mutation resulted in a dramatic increase in both spore resistance 
to acid/heating and swelling during germination.
DD-CPases are usually anchored to cell membranes at their N-terminus, and their active sites are exposed 
to the periplasmic space in which they catalyze the final stages of cell wall biosynthesis11. SCO4439 is very 
unusual, because in addition to the DD-CPase domain, it harbors an additional putative transcriptional reg-
ulator domain. Other DD-CPases, including most HMM DD-CPases, are multi domain proteins and harbor 
glycosyl transferase domains involved in cell wall maturation11. However, to our knowledge, SCO4439 is the first 
DD-CPase that is associated with a putative transcriptional regulatory domain. SCO4439 has a high molecular 
mass of 84 kDa, resulting in its classification as an HMM DD-CPase. However, the DD-peptidase domain of 
Figure 4. Structure of SCO4439 and orthologous proteins in the Streptomyces genus. (a) Scheme indicating 
the structure of the SCO4439 protein. Conserved database domain (CDD) references and their average 
similarities in the Streptomyces genus are indicated. SCO4439 fragments introduced in plasmids pBRB3, pBRB4, 
pBRB5 and pBRB6 are shown schematically. Fragments that complemented the phenotype in the mutant strain 
are highlighted in red. (b) Sequence alignment of the DD-CPase domain of SCO4439 (S. coelicolor) and their 
orthologs in other model streptomycetes. Conserved “SxxK”, “SxN” and “KTG” motifs that characterize the 
“SxxK” superfamily of DD-peptidases are indicated. An asterisk indicates the Leu684 whose replacement by Pro 
partially blocks complementation of the wild type phenotype in the SCO4439::Tn5062 mutant.
www.nature.com/scientificreports/
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SCO4439 is homologous to LMM DD-peptidases and exhibits the DD-CPase activity that is peculiar to LMM 
DD-peptidases11. The putative transmembrane domain of SCO4439 is located in the middle of the protein, sepa-
rating the DD-CPase and the putative transcriptional regulator domains, which is also unusual. The (1) Phobius 
prediction of the protein structure, (2) the presence of DD-CPase activity only in S. coelicolor insoluble fractions 
(membranes and cell wall debris) (Fig. 5d) and (3) the presence of the essential nature of the transmembrane 
domain for biological activity (Fig. 4a) suggest that the DD-CPase domain is exposed to the periplasmic space, 
whereas the putative transcriptional regulatory domain is likely located on the cytosol side of the cell membrane. 
Further work is required to understand the biological function, if any, of the putative transcriptional regulatory 
domain located at the N-terminus of SCO4439. The presence of this domain in all SCO4439 orthologs suggests 
that it may have a relevant function (Fig. 4). In contrast, its relatively low conservation (44% average similarity), 
its exclusive occurrence in streptomycetes, and finally, its unessential role in complementing the spore germi-
nation and resistance phenotypes in the SCO4439::Tn5062 mutant may indicate that this domain has not an 
essential function.
Spore germination comprises a succession of distinctive steps that were organized by Hardisson et al.22 into 
three stages: darkening, swelling, and germ tube emergence (Fig. 7). The biomolecular mechanisms controlling 
these stages remain poorly characterized23–25. There are two examples of proteins known to be involved in 
Streptomyces spore germination. NepA was described as a structural cell wall protein involved in the maintenance 
of spore dormancy in S. coelicolor26. SsgA was identified as a protein marking cell-wall sites in which germination 
takes place27. The phenotype of the SCO4439::Tn5062 mutant observed in this work indicates the existence of a 
new stage that includes the deswelling of the spores once they cannot resist further swelling. The occurrence of 
Figure 5. Purification of recombinant His6-SCO4439/ His6-SCO4439*, SCO4439 activity and cellular 
localization. (a) Coomassie-stained SDS-PAGE gel of overproduced His6-SCO4439 and His6-SCO4439* 
(substitution of Leu684 for Pro684). M, molecular weight markers. Lane 1, E. coli JM109 producing His6-SCO4439 
(45 μ g). Lane 2, E. coli JM109 producing His6-SCO4439* (45 μ g). Lane 3, purified His6-SCO4439 (4 μ g). Lane 4  
purified His6-SCO4439* (4 μ g). (b) DD-CPase and DD-dipeptidase activities of His6-SCO4439 and His6-
SCO4439*. Enzyme activity values (units per mg of pure recombinant protein) are the average ± SD of three 
replicates. (c) His6-SCO4439 penicillin inhibition curve. (d,e) DD-CPase and DD-dipeptidase activity (units 
per mg of total protein) detected in insoluble fractions (membrane and cell wall debris) of S. coelicolor wild 
type and of SCO4439::Tn5062 mutant strains. (f) PG crosslinking in the spores of the SCO4439::Tn5062 mutant 
(SCO4439 mutant), S. coelicolor wild type (wt), SCO4439::Tn5062 complemented with pBRB3 (complemented 
mutant), the control wild type strain harboring pMS82 (wt pMS82), and the SCO4439::Tn5062 mutant 
complemented with pBRB3* (SCO4439 mutant [pBRB3*]). Values are the means ± SD of two biological 
replicates, and four technical replicates.
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this stage was demonstrated via time-lapse microscopy in both the wild type and the SCO4439::Tn5062 mutant 
(Supplementary Movies 1 and 2; Fig. 1m,n). In the wild-type strain, spore deswelling coincided with germ tube 
emergence, whereas the spores of the SCO4439::Tn5062 mutant continued to swell after the emergence of the 
germ tube (Fig. 7). In the partially complemented SCO4439::Tn5062 mutant (the strain complemented with the 
SCO4439* mutated gene), spore swelling persisted also after germ tube emergence, but the maximum swelling 
Figure 6. Nascent-PG synthesis during germination. (a–d) S. coelicolor wild type. (e–j) SCO4439::Tn5062 
mutant. (k–n), (SCO4439::Tn5062[pBRB3] complemented strain. GYM liquid cultures were stained with 
BODIPY-vancomycin, and observed at the confocal microscope. The interference contrast mode (left pictures) 
and fluorescent images (right pictures) are shown. Arrows indicate nascent PG. Developmental time points are 
indicated. Scale bars represent 4 μ m.
Figure 7. Model for the biological function of SCO4439. (a) S. coelicolor wild type. (b) SCO4439::Tn5062. 
Classical germination stages: darkening, swelling and germ tube emergence24. The proposed spore deswelling 
stage is indicated. Green illustrates the membrane-intact cells (SYTO 9 staining); red indicates propidium 
iodide (PI) permeable cells (lysis). D-iGlx, D-iso-glutamine or D-iso-glutamic acid. See text for details.
www.nature.com/scientificreports/
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was lower than in the mutant (maximum spore diameter of 3.9 μ m vs. the 4.6 μ m reached in the mutant; Fig. 1p,q; 
Supplementary Movies 2 and 4).
The proposed biomolecular model to account for the observed phenotypes in the SCO4439::Tn5062 mutant 
is schematized in Fig. 7. Accordingly, a deficiency in SCO4439 DD-CPase increments the pool of available trans-
peptidase substrates (PG pentapeptides), thereby enhancing the activity of these enzymes and promoting the for-
mation of PG crosslinks. Spores with highly crosslinked PG are more resistant to heating and acid and swell more 
slowly at early germination time points, but they can reach greater dimensions before lysing due to osmotic shock 
(Fig. 7). The mutation in SCO4439 that replaces Leu684 with Pro684, halved the native DD-CPase activity, and when 
the SCO4439* gene was introduced into the SCO4439::Tn5062 mutant, the phenotype was only partially restored. 
This demonstrates that spore swelling during germination is proportional to SCO4439 DD-CPase activity. The 
model proposed in Fig. 7 would also be valid for new PG synthetized in the SCO4439::Tn5062 mutant after spore 
germination, at the latest stages of the swelling, which will have more cross-linking than the wild strain.
Streptomyces mutants created in germination such as SCO4439::Tn5062, represent a key tool that provides 
insight into this process. Up to now, the osmotic mechanism controlling spore swelling is largely unknown. Germ 
tube emergence is marked by SsgA27, and uncharacterized lytic enzymes regulate the splitting of the spore covers 
at this germination point28. Spore swelling may facilitate the emergence of the germ tube22, and germ tube emer-
gence coincides with the end of the swelling in the S. coelicolor wild type strain (Fig. 1m). The dramatic swelling of 
the spores in the SCO4439::Tn5062 mutant after germ tube emergence suggests that the high osmotic pressure in 
the spore cytoplasm feeds this swelling. In the weaker spores of the wild-type strain (low PG crosslinking), spore 
swelling culminate with the emergence of the germ tube. However, spores of the SCO4439::Tn5062 mutant have 
higher PG crosslinking, and the swelling continues after the emergence of the germ tube. In this scenario, the cells 
likely still detect the high osmotic pressure that in normal conditions would indicate the absence of germination, 
thus they increase swelling and osmotic pressure to facilitate germination (Fig. 7). Further work is required to 
fully comprehend this phenomenon. Interestingly, some studies have already suggested a role for PBPs in spore 
germination in other sporulating bacteria such as Bacillus. Neyman and Buchanan29 and Murray et al.30 described 
how some DD-peptidases are expressed differentially during Bacillus sporulation and germination, and Buchanan 
and Gustafson31 showed that dacB mutants produce spores with unusual resistance to chemicals and heating in 
Bacillus.
The lack of the DD-CPase activity in SCO4439::Tn5062 mutant strain increases the pool of PG pentapep-
tide, the terminal D-Ala-D-Ala dipeptides of which are the molecular target of glycopeptide antibiotics32. 
Consequently, the mycelium of the SCO4439::Tn5062 mutant was more sensitive to vancomycin and teicoplanin 
than the mycelium of the wild-type strain (Fig. 3f). S. coelicolor resistance to vancomycin (but not to teicoplanin), 
was described to be due to the canonical set of vanRSHAX genes induced by vancomycin (but not by teicoplanin) 
that are responsible for replacing the terminal D-Ala-D-Ala dipeptides with the resistant D-Ala-D-Lac dipep-
tides33,34. Recent work demonstrated that other enzymes (VanY-like) contribute to glycopeptide resistance in 
actinomycetes by removing the last D-Ala from the PG-pentapeptide precursors34,35. Interestingly, these enzymes 
are membrane-associated LMW DD-CPases with a minor activity on dipeptides and are in some cases inhibited 
by β -lactams35,36.
The SCO4439 DD-CPase gene is constitutively expressed (Fig. 2e), whereas the specific DD-CPase enzymatic 
activity decreases during development (from 5 U/mg protein at 16 hours, to 3 U/mg protein at 72 hours) (Fig. 5d). 
This can be a consequence, that, at later time points, most of the mycelium suffers a programmed cell death1,2 
disrupting cell membrane integrity and experiencing an increasing proteolytic activity. Loss of DD-CPase activity 
may be due to the increasing protein instability in the above conditions. Anyhow, the occurrence of other specific 
post-translational modifications regulating the DD-CPase activity cannot be ruled out.
Overall, this work demonstrates that the SCO4439 DD-CPase regulates the proportion of PG crosslinking 
in the spore cell walls, a process that is critical for the regulation of spore germination. The SCO4439 DD-CPase 
gene is constitutively expressed, and its activity is present in the Streptomyces vegetative hyphae. However, its 
biological role in the mycelium (beyond the increase of resistance to glycopeptide antibiotics) remains unknown. 
Knowledge of the biological role of the genes involved in antimicrobial resistance is important to understand the 
evolution of resistance in nature.
Methods
Bacterial strains and media. Bacterial strains are listed in Table 1. Streptomyces coelicolor M145 was the 
reference strain and was used to generate the mutants. Petri dishes (8.5 cm) with 25 ml of solid GYM medium 
(glucose, yeast/malt extract)37 were covered with cellophane disks, inoculated with 100 μ l of a fresh spore suspen-
sion (1 × 107 viable spores/ml), and incubated at 30 °C. Spores were obtained from SFM solid cultures38.
Escherichia coli strains were grown at 37 °C in solid (2% agar) or liquid 2xTY medium39 supplemented with 
the appropriate antibiotics (Table 1).
Disruption of SCO4439. The transposon insertion single-gene knockout library created by Prof. P. 
Dyson’s research group16 was used for mutagenesis of SCO4439. Cosmid D6.2.B06 was used to construct the 
SCO4439::Tn5062 mutant strain (Table 1). Gene disruption was carried out by obtaining double cross-overs via 
conjugation using E. coli ET12567/pUZ8002 as a donor strain and following the protocol described in Kieser 
et al.38. Mutant strains were confirmed using Southern blotting with chromosomal DNA digested with SalI. 
Southern hybridization was carried out using established procedures with the digoxigenin-labeled 3442-bp 
Tn5062 PvuII fragment from plasmid pQM506240 as a probe.
Complementation of SCO4439::Tn5062 mutation. The integrative plasmid pMS8241 was used to 
introducedifferent fragments from the SCO4437-SCO4442 chromosomal region into the SCO4439::Tn5062 
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mutant. Fragments were amplified via PCR using Phusion High-Fidelity DNA Polymerase (Thermo), and were 
then cloned into pCR™-Blunt II-TOPO® . The sequences were checked via DNA sequencing using the M13 
universal primers prior to subcloning them into pMS82. The following plasmids were constructed (Table 1): 
pBRB1 containing the SCO4440-SCO4442 fragment amplified with primers BRB1F/BRB1R; pBRB2 containing 
Strain, plasmid, cosmid Description Reference
Bacterial strains
 S.coelicolor M145 SCP1− SCP2− 38
 S.coelicolor SCO4439::Tn5062 SCO4439-40::Tn5062, AmR This study
 E. coli TOP10 F- mcrA Δ (mrr-hsdRMS-mcrBC) ϕ 80lacZΔ M15 Δ lacX74 nupG recA1 araD139 Δ (ara-leu)7697 galE15 galK16 rpsL(StrR) endA1 λ − Invitrogen
 E. coli JM109 (DE3) E. coli JM109 containing a chromosomal copy of the gene for T7 RNA polymerase Promega
 E. coli ET12567 dam-13::Tn9, dcm-6 52
 E. coli ET12567/pUZ8002 E. coli ET12567 containing plasmid pUZ8002, a not self-transmissible plasmid which can mobilize other plasmids 53
Plasmids & cosmids
 pQM5062 Plasmid containing eGFP Tn5062 40
 pMS82 Cloning vector, HygR 41
 pBRB1 SCO4440-4442 harbouring its own promoter cloned into pMS82/SpeI/EcoRV, HygR This study
 pBRB2 SCO4437-4439 harbouring its own promoter cloned into pMS82/SpeI/EcoRV, HygR This study
 pBRB3 SCO4439 harbouring its own promoter cloned into pMS82/SpeI/EcoRV, HygR This study
 pBRB3* SCO4439 harbouring its own promoter containing a mutation (Leu684 was changed by Pro) and cloned into pMS82/SpeI/EcoRV, HygR This study
 pCR™-Blunt II-TOPO®  Zero Blunt®TOPO®PCR Cloning Kit, KmR Invitrogen
 pTOPO4439 SCO4439 harbouring its own promoter cloned into pCR™ -Blunt II-TOPO®, KmR This study
 pTOPO4439-P-N pTOPO4439 digested with NruI and SpeI (filled blunt) and religated, KmR This study
 pTOPO4439-P-C pTOPO4439 digested with AfeI and NruI and religated, KmR This study
 pTOPO4439-P SCO4439 promoter cloned into Blunt TOPO, KmR This study
 pTOPO4439-T-C Transmembrane region and carboxyl end of SCO4439 cloned into pCR™-Blunt II-TOPO® , KmR This study
 pTOPO4439-P-T-C pTOPO4439-P digested with EcoRV/NdeI and cloned in pTOPO-4439-T-C digested with EcoRV/NdeI, KmR This study
 pBRB4 Fragment EcoRV/HindIII from pTOPO4439-P-N cloned in HindIII and KpnI (filled blunt) of vector pMS82, HygR This study
 pBRB5 Fragment EcoRV/SpeI from pTOPO4439-P-C cloned in EcoRV/SpeI of pMS82/SpeI/EcoRV, HygR This study
 pBRB6 Fragment EcoRV/SpeI from TOPO4439-P-T-C cloned in EcoRV/SpeI of pMS82/SpeI/EcoRV, HygR This study
 pET11a Cloning/expression vector, ApR Novagen
 pBRB7 His-SCO4439 cloned in pET11a/NdeI/BamHI, ApR This study
 pBRB7* His-SCO4439 containing a mutation (Leu684 was changed by Pro) cloned in pET11a/NdeI/BamHI, ApR This study
 D6.2.B06 D6 cosmid carrying D6.2.B06 transposant 18
Primers
 BRB1F 5′ AAAAAGATATCGTCTCGCGGACCGACAGC 3′ This study
 BRB1R 5′ CCCACTAGTAACTGGTCGAGAGGGCTCC 3′ This study
 BRB2F 5′ AAAAAGATATCACCGAGGTCGAGCGACTG 3′ This study
 BRB2R 5′ CCCACTAGTGCTCACCAGCGACAATGAGG 3′ This study
 BRB3R 5′ CCCACTAGTGTTTGGCGACGCTAGCAC 3′ This study
 BRB6R 5′ AACATATGCGCCAGCCGCGGATCAC 3′ This study
 BRB6F 5′ AACATATGACCACCCAGCAGCCGCTG 3′ This study
 BRB7F 5′ TTCATATGCATCATCATCATCATCATGTGGCCCGGGAGGACG 3′ This study
 BRB7R 5 GGGGATCCGTTTGGCGACGCTAGCAC 3′ This study
 SCO4848F 5′ CGTCGTATCCCCTCGGTTG 3′ This study
 pMS82R 5′ GAGCCGGGAAAGCTCATTCA 3′ This study
 SCO4439-qRTPCR-F 5′ GGCGTTCGTGGAGAAGATG 3′ This study
 SCO4439-qRTPCR-R 5′ CTCACCGTCGTGTTGTTCAG 3′ This study
Table 1.  Bacterial strains, plasmids and primers used in this study. The pairs of primers used to amplify 
fragments cloned in plasmids pBRB1-7 and pTOPO4439-P-N-T-C are described in the Materials and Methods 
section.
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the SCO4437-SCO4439 fragment amplified with primers BRB2F/BRB2R; pBRB3 containing SCO4439 amplified 
with primers BRB2F/BRB3R. One of the amplified SCO4439 fragments cloned in pCR™-Blunt II-TOPO® had 
a mutation generated during the PCR that replaced Leu684 with Pro; this mutation was also cloned into pMS82 
generating plasmid pBRB3*. In all cases, primers were designed to hybridize at least 250 bps before the ATG of 
the ORFs to encompass the promoter region.
Three additional pMS82-derived plasmids were constructed containing different parts of the multidomain 
SCO4439 gene: one harboring the SCO4439 N-terminus and the other two harboring two regions of the SCO4439 
C-terminus. The SCO4439-N-terminus truncated gene was generated in two steps: first, the whole SCO4439 
gene was amplified with primers B2F/B3R and cloned into pCR™-Blunt II-TOPO®, selecting for the plasmid 
in which the C-terminus of the SCO4439 gene was orientated to the SpeI side of the pCR™-Blunt II-TOPO® 
(pTOPO4439); second, the DD-CPase domain was deleted by digesting pTOPO4439 with NruI and SpeI, 
the SpeI cohesive end was filled with the Klenow DNA polymerase, and the plasmid was religated to gener-
ate pTOPO4439-P-N. A stop codon (TAG) from the SpeI restriction site was formed in the correct ORF. Two 
C-terminus constructions were performed, one including the 5′ region of the gene (promoter and RBS) followed 
by the DD-CPase domain (SCO4439-P-C), and the second including the 5′ region followed by both the trans-
membrane and DD-CPase domains (SCO4439-P-T-C). SCO4439-P-C was generated by digesting pTOPO4439 
with AfeI and NruI, and re-ligating the plasmid. pTOPO4439-P-C, lacked the AfeI-NruI fragment (the puta-
tive transcriptional regulatory and transmembrane domains) but conserved the 5′-region and the open read-
ing frame. SCO4439-P-T-C was created in three steps: first the 5′ region was amplified with primers BRB2F/
BRB6R and cloned into pCR™-Blunt II-TOPO® (pTOPO4439-P); second, the SCO4439 C-terminus (including 
the transmembrane and DD-CPase domains) was amplified with BRB3R/BRB6F and cloned into pCR™-Blunt 
II-TOPO® , and the plasmid in which the NdeI (introduced in primer BRB6F) orientated to the EcoRV side of the 
pCR™-Blunt II-TOPO® was selected, to generate pTOPO4439-T-C; and third, the promoter region was released 
from pTOPO4439-P with EcoRV-NdeI and cloned into pTOPO-T-C digested with the same enzymes to gen-
erate pTOPO4439-P-T-C. pTOPO4439-P-T-C conserved the open reading frame of the transmembrane and 
DD-CPase domains. The three truncated genes were subcloned into pMS82, generating plasmids pBRB4, pBRB5 
and pBRB6 (Table 1).
The seven pMS82-derived plasmids (pBRB1-pBRB6 and pBRB3*) were independently conjugated into the 
SCO4439::Tn5062 strain as indicated above. The integration of these plasmids into the pMS82 integration site 
(gene SCO4848)41 was verified by PCR using primers SCO4848F (hybridizing with the SCO4848 gene) and 
pMS82R (hybridizing with pMS82). Plasmid integration was confirmed via the generation of a 617-bp amplicon.
Viability staining. Culture samples were obtained and processed for microscopy at various incubation dura-
tions, as previously described42. The cells were stained with propidium iodide and SYTO 9 (LIVE/DEAD Bac- 
Light Bacterial Viability Kit, Invitrogen, L-13152). The samples were observed under a Leica TCS-SP8 confocal 
laser-scanning microscope at wavelengths of 488 nm and 568 nm excitation and 530 nm (green) or 640 nm (red) 
emissions42. More than 30 images were analyzed for each developmental time point in a minimum of three inde-
pendent cultures. For spore diameter quantification, the images were calibrated with Image J, and the diameter of 
at least 100 spores was quantified for each strain and developmental time point (Supplementary Figs S1 and S2). 
These images included pictures from at least three biological replicates.
Time-lapsed (live) imaging. Initially spores were incubated on GYM medium; after 6 hours of incubation, 
the samples were cut out and inverted into uncoated m-dishes (Ibidi GmbH). The lid was turned so it was sup-
ported on the vents, allowing gas exchange, and sealed off by two layers of Parafilm to prevent medium drying. 
The samples were incubated at 30 °C and imaged with a Leica TCS-SP8 confocal laser-scanning microscope. 
Images were taken using the interference contrast mode (unstained samples) every 10 minutes for 12 hours. 
Time-lapse images were processed with Image J. Time lapse experiments were limited to 12 hours because pro-
longed incubations dry the culture medium and interfere with hyphal growth.
RNA extraction and Real-Time Quantitative Reverse Transcription PCR (qRT-PCR). Total RNA 
samples from three biological replicates of each developmental time point were obtained. Approximately 100 mg 
of mycelia (fresh weight) were scraped from the GYM-cellophane medium using a plain spatula. Five hundred 
microliters of RNA Protect Bacteria reagent (Qiagen) were added to the mycelia to provide immediate RNA 
stabilization. The extraction was carried out using the RNeasy Mini Kit (Qiagen). The lysis step was made using 
Fast-Prep (MP™ Biomedicals) with two 30-s force 6.5 cycles, with 1 minute on ice between each run. A phenol 
acid extraction was performed immediately prior to applying the samples to the column. Treatments with DNase I 
(Qiagen) and TURBO DNA-freeTM kit (Ambion) were performed to eliminate possible chromosomal DNA 
contamination. RNA integrity was verified using a 2100 Bioanalyzer (Agilent).
Quantitative RT-PCR (qRT-PCR) was performed as previously described by Yagüe et al.15. Relative quantifica-
tion of gene expression was calculated using the (REST) software tool43. Primer efficiencies were measured using 
different dilutions of genomic DNA as templates.
Resistance of spores to sonication, lysozyme, mild acid, heating and freezing. Freshly prepared 
suspensions of spores were prepared at a concentration of 108 spores/ml in sterile distilled water, and subjected 
to different treatments as detailed below. Germination of the spores prior to and after treatment were analyzed by 
plating and quantifying the number of colony-forming units. All quantifications were performed in triplicate, and 
the data correspond to the average ± SD of the replicates.
For sonication, 2 ml of spores were treated in an MSE Soniprep (six cycles of 15 seconds of sonication, 1 min-
ute on ice). For lysozyme incubation, 1 ml of spores was treated with a concentration of 50 μ g/ml freshly prepared 
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lysozyme (Sigma-Aldrich, L6876) and incubated at 37 °C for 30 minutes. For mild acid treatment, 0.2 ml of spores 
were incubated with 0.1 N of HCl for 5 minutes at 25 °C; acid was neutralized via 20-fold dilution in 50 mM potas-
sium phosphate buffer (pH 7.1). For heating, the spores were heated at 55 °C for 90 minutes. For freezing, the 
spores were stored at − 20 °C for 24 hours.
Determination of the minimum inhibitory concentration (MIC). Minimum inhibitory concentra-
tions (MICs) of teicoplanin and vancomycin (Sigma-Aldrich V1130 and T0578) were determined in GYM by 
adding increasing concentrations of glycopeptides. The inoculum was 105 spores/plate, and the plates were incu-
bated at 30 °C until colonies appeared. The MIC was the lowest concentration of the antibiotic that inhibited the 
visible growth of S. coelicolor44,45. The experiments were performed in triplicate, and were highly reproducible 
with a variation of zero.
SCO4439 and SCO4439* gene overexpression and protein purification. The SCO4439 and 
SCO4439* (SCO4439 mutated in Leu684) genes were amplified with primers BRB7F/BRB7R from pBRB3/pBRB3* 
and cloned into the expression vector pET11a (Novagen) to generate pBRB7/pBRB7*. A His6 tag was included 
at the 5′ -terminus of the BRB7F primer. The SCO4439/SCO4439* genes were overexpressed in E. coli JM109 
(DE3) using the MagicMedia E. coli Expression Medium (Invitrogen K6803). The expression was performed at 
18 °C for 36 hours following the manufacturer’s protocol. The cells were harvested via centrifugation, resuspended 
in buffer A (20 mM sodium phosphate, 0.5 M NaCl, 40 mM imidazole, complete EDTA-free Protease Inhibitor 
Cocktail Tablets from Roche, pH 7.4) and ruptured using Fast-Prep (MP™ Biomedicals) with ≤ 106 μ m beads 
(Sigma-Aldrich, G8893) and three 20-s force 6.5 cycles, with 1 minute on ice between each run. Finally, the sam-
ples were centrifuged at 7,740 × g for 15 minute at 4 °C. The resulting supernatant fraction was centrifuged at 
100,000 × g for 1 hour at 4 °C, and the supernatant was used for protein purification.
Recombinant His6-SCO4439/ His6-SCO4439* were purified using 1 ml HisTrap HP affinity columns from GE 
Healthcare (reference 17-5247-01). Buffer A, described above, was used as a binding buffer; the elution buffer 
was similar but contained 500 mM imidazole. The protein was purified using an Amersham Pharmacia FPLC 
(LCC 500 plus controller and two P500 pumps). Purification was performed at 4 °C using a flow of 1 ml per 
minute, a 20 ml linear elution gradient, and collecting fractions of 500 μ l. Fractions were analyzed via SDS-PAGE 
Coomassie gels, and those containing the overproduced protein were combined, quantified by Bradford46, and 
used for further experiments.
Mass spectrometry analysis. The identity of the overproduced protein was confirmed via peptide mass 
fingerprinting. The overproduced purified His6-SCO4439 protein was manually excised from a 1D Coomassie 
gel, and the proteins were digested following the method of Havlis et al.47, and analyzed using a 4800 Proteomics 
Analyzer matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF/TOF) mass spectrometer (AB 
Sciex). Protein identification, was performed using Mascot v. 2.2.04.
Assay of DD-dipeptidase and DD-carboxypeptidase activities. Enzymatic activities were assayed as 
reported previously35,45 by measuring the release of D-Ala from commercially available dipeptide (D-Ala-D-Ala, 
10 mM; Sigma-Aldrich, A0912) and tripeptide (Nα,Nε-diacetyl-l-Lys-D-Ala-D-Ala, 10 mM; Sigma-Aldrich, 
D9904) in the reaction buffer (100 mM Tris-HCl, pH 7.2), together with different amounts of the purified recom-
binant His6-SCO4439 or His6-SCO4439*. The release of D-Ala was followed spectrophotometrically with a 
D-amino acid oxidase (Sigma-Aldrich, A5222)-peroxidase (Sigma-Aldrich 77332) coupled reaction that oxi-
dized the colorimetric substrate 4-aminoantipyrine (Sigma-Aldrich 06800) to chinonemine in the presence of 
phenol solution (Sigma-Aldrich P4557)35,48. One unit of enzyme activity is defined as the amount of enzyme that 
produced 1 μ mol D-Ala per minute from the tripeptide as substrate; this value must be halved when the dipeptide 
is used as substrate. To measure the inhibition of DD-CPase/DD-dipeptidase activity, the protein was incubated 
with increasing concentrations (from 0 to 5 mM) of penicillin G (Sigma-Aldrich, P3032) for 15 minutes at 37 °C 
and then added to the assay mixtures. All measurements were performed in triplicate, and the data correspond 
to the means ± SD.
Cellular fractioning. S. coelicolor and the SCO4439::Tn5062 mutant were grown in solid GYM medium as 
described above for 16, 30 and 72 hours at 30 °C. The mycelium collected from cellophane discs were suspended 
in 2 ml of 0.9% NaCl per gram of cells (wet weight). All of the following manipulations were carried out at 0 to 
4 °C, and all solutions contained proteinase inhibitors (0.19 mg/ml phenylmethanesulfonyl fluoride and 0.7 g/ml 
pepstatin, both purchased from Sigma-Aldrich P7626 and P5318), unless otherwise stated. Mycelia were frag-
mented by sonication with a Sonics Vibra-Cell VCX 130. Sonication was carried out for 5 minutes on ice with 
cycles of 30 seconds with an amplitude of 90% (90% of 60 Hz), and breaks of 10 seconds. The samples were then 
centrifuged at 39,000 × g for 15 minutes, and the supernatants (cytoplasmic fractions) were collected. Alkaline 
extraction of the insoluble fraction (membranes and cell wall debris) was carried out by adapting a previously 
developed protocol for extracting membrane-bound proteins in enterococci by Kariyama et al.49 and recently 
adapted to Streptomyces by Binda et al.43. The sedimented pellets were resuspended in ice-cold distilled water; 
immediately prior to centrifugation (28,000 × g for 15 minutes at 4 °C), the pH was adjusted to 12 by adding an 
appropriate volume of 2.5 N NaOH. Immediately after centrifugation, the supernatants (resuspended insoluble 
fractions) were neutralized to pH 7 by adding 0.5 M sodium acetate (pH 5.4)35,36,45. Enzymatic activities in the 
cytosolic fractions and the re-suspended insoluble fractions were assayed as previously reported36,45.
FDNB determination of spore PG crosslinking. The protocol described by Atrih et al.50 to analyze the 
PG crosslinking in the spores of Bacillus was adapted to S. coelicolor. The protocol for PG extraction was mod-
ified as follows: spores were collected from solid SFM media38; the concentration of spores used for extraction 
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was 3 mg (dry weight) per ml of extraction buffer; FDNB treatment was performed using 200 μ l of the extracted 
spore cell walls. This protocol works for the analysis of the PG from Streptomyces spores, but not for mycelium, 
perhaps due to the difficulty to homogenize the dense pellets of the mycelium, making PG poorly accessible to the 
extraction and FDNB treatment.
Glycine and diaminopimelic acid (Dpm) were measured via high-performance liquid chromatography 
using pre-column derivatization with o-phthaldehyde (OPA) and UV detection (338 nm). The chromatographic 
equipment used included the Agilent 1100 HPLC System: a G1312A binary pump, G1329A autosampler, and 
G1315B-Diode Array Detector. Data collection and integration were performed using Software Chem Station 
LC 3D. The column used was a 250 × 3.9 mm, 100 Å, Symmetry C18 (5 μ m) (WAT046980) from Waters. The 
binding buffer (10 mM Na2HPO4, 40 mM boric acid, pH 8.15) and the elution buffer (MeOH:ACN:H2O; 45:45:10, 
v/v/v) were filtered (0.45 μ m) prior to use. Samples were eluted in an increasing gradient of elution buffer (20% 
for 1.9 minutes, 70% for 13 minutes; 100% for 2.7 minutes) with a flow of 1ml /minute. The column temperature 
was 40 °C, the injection volume 20 μ l, and the detection of the amino acids was at 338 nm. Pure glycine and Dpm 
(both from Sigma-Aldrich) were used as standards.
The crosslinking index defined by Atrih et al.50 is based on the difference between the Dpm measured in the 
FDNB-treated and untreated samples. FDNB treatment is performed prior to PG hydrolysis and blocks NH 
groups of the Dpm residues that have not formed crosslinks. NH groups blocked with FDNB cannot react with 
the derivative reagent used for HPLC UV detection. S. coelicolor differs from Bacillus, and PG crosslinking is 
formed by Gly instead of Dpm51. Consequently, in this work, the crosslinking index was calculated as the ratio 
between the cross-linked Gly (Gly detected in the FDNB-treated samples) and total Gly (Gly detected in the 
non-treated samples). Dpm was used to normalize the glycine measurements (expressed as a ratio to Dpm).
Bioinformatic analyses. Transmembrane topology of the SCO4439 gene was analyzed using Phobius soft-
ware (http://phobius.sbc.su.se/).
Orthologous sequences to SCO4439 from other streptomycetes were obtained from the databases at the 
National Center for Biological Information (http://www.ncbi.nlm.nih.gov). The accession numbers of the 
selected sequences were: WP_016326920 (S. lividans), NP_824958 (S. avermitilis), YP_006878621 (S. venezue-
lae), WP_013002845 (S. scabies), YP_001825771 (S. griseus), and WP_003961441 (S. clavuligerus). The DD-CPase 
domains of the proteins were aligned using MUSCLE software, and amino acid similarities were estimated by 
using Lalign software (http://www.ch.embnet.org/software/LALIGN_form.html).
Fluorescent vancomycin staining. Nascent PG synthesis was stained in Streptomyces liquid cultures 
growing in GYM medium37, inoculated with spores at a concentration of 1 × 107 viable spores/ml, and incubated 
at 30 °C and 200 rpm for 5 and 8 hours. The samples were stained as previously described20. BODIPY-vancomycin 
(Invitrogen V34850) was mixed with an equal amount of unlabeled vancomycin (Sigma SBR00001). The van-
comycin and BODIPY-vancomycin mixtures were added to the cultures at final concentrations of 1 μ g/ml and 
incubated for 20 minutes. Cells were fixed for 15 minutes at room temperature using PBS (0.14 M NaCl, 2.6 mM 
KCl, 1.8 mM KH2PO4 and 10 mM Na2HPO4) containing 2.8% paraformaldehyde and 0.0045% glutaraldehyde, 
and observed under a Leica TCS-SP8 confocal laser scanning microscope at 505 nm excitation and 513 nm emis-
sion wavelengths.
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